2011 Anniversary Yearbook - EUFEPS today and history

More documents

Recommendations

Info

5. Individual Memberships Representatives to Council The body of Individual Members is represented by delegates to the Council. The delegates are elected biennially by written ballot 4 months prior to the Council to serve for a term of two years. A delegate may serve for a maximum consecutive period of four years. Current delegates are: Professor Ole J. Bjerrum University of Copenhagen, Copenhagen, Denmark Email ojb@farma.ku.dk Dr Natasa Jovanovic BioConnection, Oss, The Netherlands Email natasakomal@yahoo.com Professor Amin Rostami University of Manchester, Manchester, United Kingdom Email amin.rostami@manchester.ac.uk Dr Sven Stegemann Capsugel, Bornem, Belgium Email sven.stegemann@pfizer.com 24
Effective as of September 24, 2006 1 Objectives of the Federation 6. The Statutes of EUFEPS The European Federation for Pharmaceutical Sciences (hereinafter referred to as the Federation) is a voluntary association of pharmaceutical scientists, established to advance research in the pharmaceutical sciences in Europe. This can be achieved by promoting cooperation between national, regional and European societies or associations which aim at the advancement of pharmaceutical sciences, and by promoting cooperation between and with other pharmaceutical organisations and between individual pharmaceutical scientists. The Federation seeks to achieve its objectives by the following means: A To facilitate the exchange of scientific information between European pharma ceutical scientists by • organising a European Pharmaceutical (Pharm) Sciences (Sci) Congress or Fair, at regular intervals and in different European countries; • organising specialised meetings on relevant topics of multidisciplinary aspects of drug research; • encouraging the organisation of joint meetings between member societies; publication of a European Journal of Pharmaceutical Sciences. B To collect and disseminate information on the activities of the member societies, including the production of a calendar of events. C To enhance the recognition of the pharmaceutical sciences and to contribute to public policies relevant to the pharmaceutical sciences and drug-related issues at the European level. D To encourage high standards of undergraduate, graduate and postgraduate education and training in the pharmaceutical sciences and to encourage exchange of relevant scientific information as well as exchange of staff and students of teaching and research institutions between the different European countries. 2 Membership and Administration A. Categories of Membership: • Member Societies; these are societies, which aim at the advancement of pharmaceutical sciences and are established in one (or more) of the Euro pean countries; • Member Institutions; these are universities and research institutions, which engage in pharmaceutical sciences and are established in one (or more) of the European countries; • Individual Members; these are individuals who support the objectives of the Federation. 25
Page 1 and 2: EUFEPS Yearbook 2011 20 th Annivers
Page 3 and 4: cal Sciences 2001 2002 2003 2004 20
Page 6 and 7: Pharma Ingredients & Services Custo
Page 8 and 9: The Gamlen Tablet Press The world
Page 10 and 11: Sustainable sponsorship of EUFEPS g
Page 12 and 13: 2. PRESIDENT’S INTRODUCTION Democ
Page 14 and 15: 4. Member Societies Academy of Phar
Page 16 and 17: Croatian Pharmaceutical Society - C
Page 18 and 19: Hellenic Society of Medicinal Chemi
Page 20 and 21: Norwegian Pharmaceutical Society No
Page 22 and 23: Romanian Society of Pharmaceutical
Page 24 and 25: Swedish Swedish Academy Academy of
Page 28 and 29: B. The membership terminates: • i
Page 30 and 31: K. The Executive Director shall •
Page 32 and 33: 7. Executive Committee 2010-2011 EU
Page 34 and 35: 8. Advisory Committees Committee on
Page 36 and 37: 9. EUFEPS Networks Scope and aim Th
Page 38 and 39: Network Environment and Pharmaceuti
Page 40 and 41: 10. Awards and Prizes EUFEPS is, si
Page 42 and 43: The New Safe Medicines Faster Award
Page 44 and 45: 12. The Pharmaceutical Sciences Fai
Page 46 and 47: 14. EUFEPS in EU Projects Since est
Page 48 and 49: 16. EUFEPS on the Global Scene Sinc
Page 50 and 51: 17. Sponsorship Recognition The cor
Page 52 and 53: Selection of articles from the EUFE
Page 54 and 55: EUFEPS Newsletter, 1992, vol. 1, is
Page 64 and 65: Frankfurt. CIR consists of a core g
Page 66 and 67: Objective 5 To enhance the recognit
Page 68 and 69: that they have reached the conclusi
Page 70 and 71: The procedure is safe and of relati
Page 76 and 77:
EUFEPS Newsletter, 2000, vol. 9, is
Page 78 and 79:
EUFEPS Newsletter, 2001, vol. 10, i
Page 80 and 81:
XXVIII
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
paradigm shift regarding the qualit
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
professionals into academia, indust
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
ecomes an issue’ in Verona (2006)
Page 112 and 113:
on which “Theology, Jurisprudence
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
important steps towards a comprehen
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
and set up their “own” programm
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
show all

2011 Anniversary Yearbook - EUFEPS today and history

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?